Buy Shares Strategy -
Buy COCP @ $0.44
RISK 4.7% -> Stop Loss $0.4193
TARGET 1 Reward: +4.7% $0.4607
TARGET 2 Reward: +11.4% $0.4900
Looking to break out of this nice wedge; RSI is looking good, STOCHASTIC is trending neutral however.
8 EMA about to cross the 34 EMA, hoping to catch the move before liftoff, with preplanned risk (stop loss) in effect.
Volume...
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza virus, SARS-CoV-2 virus, hepatitis C virus, and norovirus.
on the scanner COCP was the 2nd biggest gapper with 33%, a pullback to prior POC level at 1.54$ provided an excellent entry point for a long entry.
Trailing stop below 5 min bars and 1/2 of the position on a daily low trailing stop...
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244,...
This one just broke its bearish trend and the Bollinger Bands upper, it's looking like it will close above it today. The RSI is looking strong with room to grow. This is is going long.
Nice close above the .23 fibonacci level with the price just below the POC. The MACD is about to cross and the RSI is still very cool. I think this one has potential to break out in a big way.
Target $1.81
Second Target $2.13
COCP = many followers ask me in private how I can easily see certain movements that then happen in a very short time ... well today I put a projection with an arrow that will give you the idea of where from a certain level how in this case $ 1.20 I predict that it will be the minimum level within which the stock will have a reaction and the reaction mode will be...
COCP .... This is my monstrous alert for the end of the year 2020 .. American research with Biden is ready for the defeat of Covid and all that will be produced for the next few years, as immediate bacteriological cures .... more will be destined double billions of dollars for research than what the Trump government wanted to give ... ..WARNING this company has a...
Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded on January 2, 2014 and is headquartered in Bothell, WA.
03-06-2020, 3.5 Million Share Institutional Buy-In tells only a snippet of the overall story with this dream stock.
sec.report
To get the real grasp of what we have here, look to my previous post and take in this analogy as deeply as possible:
In the Coronavirus Market: $COCP is to Treatment what $IBIO is to Vaccines or what $OPK is to Testing.
$COCP has...
Alert set for breakout above $2.32
Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded on January...
